一种识别低风险阑尾炎儿童的新临床评分
本研究前瞻性纳入2至14岁因腹痛疑似急性阑尾炎就诊于急诊的儿童,开发并验证了包含临床症状、白细胞计数、中性粒细胞计数、C反应蛋白和钙卫蛋白的PALabS评分。推导队列278例(35.9%为阑尾炎),验证队列255例(49%为阑尾炎)。PALabS评分曲线下面积0.88(95%CI 0.84-0.92),优于PAS评分(AUC 0.76)和Kharbanda评分(AUC 0.82)。验证集中PALabS≤6分的敏感度99.2%、阴性预测值97.6%、阴性似然比0.03,可准确识别低风险阑尾炎儿童并进行密切观察。
要点
- PALabS评分由6部分组成:恶心(3分)、局灶性右下腹痛病史(4分)、中性粒细胞计数≥7500/μL(7分)、白细胞计数≥10,000/μL(4分)、C反应蛋白≥10.0 mg/L(2分)、钙卫蛋白≥0.50 ng/mL(3分)。
- 验证队列中PALabS≤6分识别低风险阑尾炎的敏感度为99.2%(95%CI 95.6-99.9),阴性预测值为97.6%(95%CI 87.7-99.6),阴性似然比为0.03(95%CI 0.00-0.18)。
- PALabS评分曲线下面积为0.88(95%CI 0.84-0.92),优于PAS评分(AUC 0.76,95%CI 0.71-0.82)和Kharbanda评分(AUC 0.82,95%CI 0.77-0.87)。
- 该评分可用于急诊识别低风险阑尾炎儿童,并对其进行密切观察管理。
适用人群与场景
- 2至14岁因腹痛疑似急性阑尾炎就诊于急诊的儿童。
诊断标准与关键阈值
- PALabS评分≤6分定义为低风险阑尾炎。
- PALabS评分组成:恶心(3分)、局灶性右下腹痛病史(4分)、中性粒细胞计数≥7500/μL(7分)、白细胞计数≥10,000/μL(4分)、C反应蛋白≥10.0 mg/L(2分)、钙卫蛋白≥0.50 ng/mL(3分)。
处置流程与药物剂量
- PALabS≤6分的低风险阑尾炎儿童可安全进行密切观察。
研究设计与关键结果
- 研究类型为前瞻性纳入并基于两个独立队列进行二次分析以开发和验证评分,推导队列278例(35.9%为阑尾炎),验证队列255例(49%为阑尾炎)。
- PALabS评分曲线下面积0.88(95%CI 0.84-0.92),优于PAS评分(AUC 0.76,95%CI 0.71-0.82)和Kharbanda评分(AUC 0.82,95%CI 0.77-0.87)。
- 验证集中PALabS≤6分的敏感度99.2%(95%CI 95.6-99.9),阴性预测值97.6%(95%CI 87.7-99.6),阴性似然比0.03(95%CI 0.00-0.18)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究(推导与验证)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急诊科,对2至14岁腹痛疑似阑尾炎的儿童可计算PALabS评分,≤6分者低风险阑尾炎,可安全进行密切观察。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Besides clinical signs and imaging, in recent years, biomarkers have proven to be a viable diagnostic resource for acute appendicitis (AA).
OBJECTIVE: The objective of this study was to develop a clinical score including clinical signs and a combination of biomarkers to identify children with abdominal pain at low risk of AA.
DESIGN/METHODS: We prospectively included children 2 to 14 years of age with abdominal pain suggestive of AA who presented to the emergency department between July 2016 and September 2017. A new score, the Pediatric Appendicitis Laboratory Score (PALabS) including clinical signs, leucocyte (WBC) and neutrophil (ANC) counts and plasma C-reactive protein (CRP) and calprotectin (CP) levels was developed and validated through secondary analyses of two distinct cohorts The validation sample included visits to a single pediatric emergency department from 2012 to 2013 and 2016 to 2017.
RESULTS: The derivation sample included 278 children, 35.9% of whom had AA and the validation sample included 255 children, 49% of whom had AA. Using logistic regression, we created a 6-part score that consisted of nausea (3 points), history of focal right lower quadrant pain (4 points), ANC of ≥7500/μL (7 points), WBC of ≥10,000/μL (4 points), CRP ≥ 10.0 mg/L (2 points) and CP ≥ 0.50 ≥ ng/mL (3 points). This score exhibited a high discriminatory power (area under the curve: 0.88; 95% confidence interval: 0.84 to 0.92) and outperformed the PAS and Kharbanda scores (area under the curve: 0.76; 95% confidence interval: 0.71 to 0.82 and 0.82; 95% confidence interval: 0.77 to 0.87, respectively). A PALabS ≤6 had a sensitivity of 99.2% (95% confidence interval [CI]: 95.6-99.9), negative predictive value of 97.6% (95% CI: 87.7-99.6), and negative likelihood ratio of 0.03 (95% CI: 0.00-0.18) in the validation set.
CONCLUSION: In our validation cohort of patients with acute abdominal pain, the new score can accurately predict which children are at low risk of appendicitis and could be safely managed with close observation.
参考来源
- Benito J, Fernandez S, Gendive M, et al. A new clinical score to identify children at low risk for appendicitis. Am J Emerg Med. 2019. PMID: 31171439. doi:10.1016/j.ajem.2019.05.050
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。